Lipocine Inc (NASDAQ:LPCN) Stock Jumped 8% Last Week After The FDA News
Shares of Lipocine Inc (NASDAQ:LPCN) closed higher last week after releasing key FDA updates. Trading Data On Friday, LPCN stock moved down 5.08% at $1.1200 with more than 775.21K shares, compared to its average volume of 878.01K shares. The stock has moved within a range of $1.0900 – 1.1800 after opening the trade at $1.1800. FDA Grants Fast Track Designation to LPCN 1144 for Treatment of Non-Cirrhotic NASH Clinical-stage biopharmaceutical…